Facebook Tracking Image

National Comprehensive Cancer Network

Members Only
NCCN Oncology Research Program (ORP)
NCCN Lilly Abemaciclib Research Grant Opportunity: Submit by Friday, July 10, 2020
Study Proposal Submission-NCCN iEnvision
NCCN Pfizer Axitinib Research Grant Opportunity: Submit by Wednesday, August 12, 2020
NCCN Pfizer Biosimilars Grant Opportunity - Submit by Wednesday, September 9, 2020
ORP Recent News
ORP Scientific Publications
ORP for Industry
ORP Investigator Steering Committee
ORP Testimonials
Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
ORP Grant History
Informed Consent Language Database
Points to Consider on the Best Practices for Biorepositories, Registries and Databases
NCCN Shared Resources
ORP Disclosure Policy
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees
NCCN Policy Priorities

NCCN Research & Business Resources

Find a clinical trial >


Established and designated by the National Cancer Institute (NCI) as one of the original comprehensive cancer centers in 1973, today the University of Wisconsin Carbone Cancer Center (UWCCC) is one of only 41 cancer centers which hold that distinction.

An integral part of the University of Wisconsin School of Medicine and Public Health and UW Hospitals and Clinics, the UWCCC unites more than 280 physicians and scientists who work together in translating discoveries from research laboratories into new treatments that benefit people with cancer. The UWCCC provides the best available cancer care to more than 31,000 patients each year and participates in more than 250 clinical trials annually. 

The UWCCC has six research programs, representing areas of specialized expertise and focus on basic, translational, clinical, and population research.

Continually ranked among the leading cancer programs in the nation by U.S. News & World Report, the UWCCC integrates and aligns patient care and research with the goals of improving patient outcomes, decreasing the burden of cancer and accelerating scientific progress.